1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR
  4. mTOR Inhibitors

mTOR Inhibitors

mTOR

mTORC1

mTORC2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

mTOR Inhibitors, Agonists, Activators & Modulators
Product Name mTOR mTORC1 mTORC2 Purity
Rapamycin  
mTOR, IC50: 0.1 nM (in HEK293 cells )
  99.94%
MHY1485  
mTORC1
mTORC2
99.93%
Everolimus  
mTOR, IC50: 5-6 nM
  99.85%
Torin 1
mTOR, IC50: 3 nM
mTORC1, IC50: 2-10 nM
mTORC2, IC50: 2-10 nM
99.28%
AZD-8055
mTOR, IC50: 0.8 nM
    99.60%
Sapanisertib
mTOR, IC50: 1 nM
    99.78%
Salidroside
mTOR
    99.90%
L-Leucine  
mTORC1
  99.79%
Temsirolimus  
mTOR, IC50: 1.76 μM
  99.56%
Dactolisib
mTOR, IC50: 20.7 nM
    99.94%
Torin 2
mTOR, IC50: 2.81 nM
mTOR, EC50: 0.25 nM (Cell Assay)
    99.65%
Dihydromyricetin  
mTORC1
mTORC2
99.73%
Omipalisib  
mTORC1, Ki: 0.18 nM
mTORC2, Ki: 0.3 nM
99.94%
PI-103  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
99.82%
RMC-5552  
mTORC1
  99.94%
JR-AB2-011    
mTORC2, IC50: 0.36 μM
98.15%
Aloe emodin    
mTORC2
98.32%
Camonsertib
mTOR, IC50: 120 nM
    99.99%
hSMG-1 inhibitor 11j
mTOR, IC50: 50 nM
    99.82%
Gedatolisib
mTOR, IC50: 1.6 nM
    99.84%
Torkinib
mTOR, IC50: 8 nM
mTORC1, IC50: 30 nM
mTORC2, IC50: 58 nM
99.03%
Vistusertib
mTOR, IC50: 2.81 nM
    99.32%
RapaLink-1
mTOR
    99.65%
3BDO
mTOR
    99.93%
Paxalisib
mTOR, Ki: 70 nM
    99.51%
hSMG-1 inhibitor 11e
mTOR, IC50: 45 nM
    99.94%
PF-04691502
mTOR, Ki: 16 nM
    99.91%
Samotolisib
mTOR, IC50: 165 nM
    99.27%
KU-0063794  
mTORC1, IC50: 10 nM
mTORC2, IC50: 10 nM
99.67%
Apitolisib
mTOR, Ki: 17 nM
    99.29%
Bimiralisib
mTOR, IC50: 89 nM
    98.62%
CC-115
mTOR, IC50: 21 nM
    99.82%
BGT226
mTOR
    99.85%
Dactolisib Tosylate
mTOR, IC50: 20.7 nM
    99.87%
Voxtalisib
mTOR, IC50: 157 nM
mTORC1, IC50: 160 nM
mTORC2, IC50: 910 nM
99.82%
OSI-027
mTOR, IC50: 4 nM
mTORC1, IC50: 22 nM
mTORC2, IC50: 65 nM
99.95%
GNE-317
mTOR
    98.76%
Ridaforolimus  
mTOR
  99.75%
Onatasertib
mTOR, IC50: 16 nM
    99.13%
PP121
mTOR, IC50: 10 nM
    99.51%
PKI-402
mTOR, IC50: 3 nM
    99.17%
VS-5584
mTOR, IC50: 37 nM
    98.71%
WYE-132
mTOR, IC50: 0.19 nM
    99.90%
mTOR inhibitor-3
mTOR, Ki: 1.5 nM
    99.79%
GSK1059615
mTOR, IC50: 12 nM
    99.76%
ETP-46464
mTOR, IC50: 0.6 nM
    99.54%
CZ415
mTOR, pIC50: 8.07
    98.39%
CC-115 hydrochloride
mTOR, IC50: 21 nM
    98.03%
BGT226 maleate
mTOR
    99.92%
Hederacolchiside A1
mTOR
    99.0%
PF-04979064
mTOR, Ki: 1.42 nM
    99.93%
Telocinobufagin
mTOR
    99.93%
PI-103 Hydrochloride  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.55%
GNE-493
mTOR, IC50: 30 nM
    99.81%
(+)-Usnic acid  
mTORC1
mTORC2
99.63%
GDC-0349
mTOR, Ki: 3.8 nM
    98.02%
Palomid 529  
TORC1
TORC2
99.37%
PQR620  
mTORC1
mTORC2
98.01%
PQR530
mTOR, Kd: 0.33 nM
    99.98%
HDACs/mTOR Inhibitor 1
mTOR, IC50: 1.2 nM
    99.01%
PKI-179
mTOR, IC50: 0.42 nM
    98.0%
PI3K/mTOR Inhibitor-2
mTOR, IC50: 4.7 nM
    99.10%
WAY-600
mTOR, IC50: 9 nM
    99.86%
XL388
mTOR, IC50: 9.9 nM
    99.74%
NSC781406
mTOR, IC50: 5.4 nM
    99.97%
mTOR inhibitor-8
mTOR
    98.14%
WYE-354
mTOR, IC50: 5 nM
    98.04%
Rotundic acid
mTOR
    99.41%
MT 63-78  
mTORC1
  98.00%
MTI-31
mTOR, Ki: 0.2 nM
mTOR, IC50: 39 nM (100 μM ATP)
    99.98%
GNE-477
mTOR, Ki: 21 nM
    98.75%
Zederone
mTOR
    99.61%
PI3K/mTOR Inhibitor-4
mTOR, IC50: 13.85 nM
   
ETP-45658
mTOR, IC50: 152.0 nM
    98.97%
HTH-01-091
mTOR, IC50: 632 nM
    98.64%
FT-1518  
mTORC1
mTORC2
98.62%
AZD3147  
mTORC1
mTORC2
99.93%
WYE-687
mTOR, IC50: 7 nM
    98.05%
PKI-179 hydrochloride
mTOR, IC50: 0.42 nM
    99.66%
GNE-490
mTOR, IC50: 750 nM
   
TML-6
mTOR
    99.01%
Pomiferin
mTOR, IC50: 6.2 μM
    98.98%
Phellodendrine
mTOR
    99.60%
CC214-2  
mTORC1
mTORC2
98.41%
FD274
mTOR, IC50: 2.03 nM
    99.45%
8-Aminoadenosine
mTOR
    99.94%
Momordicine I
mTOR
   
PI3K-IN-37
mTOR, IC50: 4 nM
    99.0%
PI3K-IN-22
mTOR, IC50: 0.6 nM
    99.50%
SN32976
mTOR, IC50: 194 nM
    99.49%
WYE-687 dihydrochloride
mTOR, IC50: 7 nM
    ≥98.0%
Coronarin A  
mTORC1
  ≥98.0%
PI3K-IN-18
mTOR, IC50: 49 nM
    99.0%
Rhodiolin
mTOR
   
PI3Kα/mTOR-IN-1
mTOR, Ki: 10.6 nM
    99.30%
HSP90/mTOR-IN-1
mTOR, IC50: 29 nM
   
PI3K/mTOR Inhibitor-1
mTOR, IC50: 186 nM
   
mTOR inhibitor-2
mTOR, IC50: 7 nM
   
PI3K/mTOR Inhibitor-9
mTOR, IC50: 38 nM (phospho-S6 cellular assay)
mTOR, IC50: 16 nM (Ser240/244 cellular assay)
   
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1)
mTOR
   
ATM Inhibitor-3
mTOR
   
ATM Inhibitor-4
mTOR
   
mTOR/HDAC-IN-1
mTOR, IC50: 0.49 nM
   
PI3K/mTOR Inhibitor-3
mTOR
   
PI3Kα-IN-5
mTOR, IC50: 3.3 nM
   
BIEGi-1  
mTORC1
 
PI3K/mTOR Inhibitor-12
mTOR, IC50: 3.12 nM
   
mTORC1-IN-3  
mTORC1, IC50: 26.38 μM
 
PI3K/mTOR Inhibitor-8
mTOR, IC50: 12 nM
   
ATR-IN-20
mTOR, IC50: 18 nM
   
Antifungal agent 106
mTOR, IC50: 0.8 μM
   
ICSN3250 hydrochloride  
mTORC1
 
PI3K/mTOR Inhibitor-14
mTOR, IC50: 10.1 nM
   
mTOR/HDAC6-IN-1
mTOR, IC50: 133.7 nM
   
PI3K/mTOR-IN-17
mTOR, IC50: 0.21 μM
   
4-TCPA
mTOR
   
mTOR inhibitor-13
mTOR, IC50: 0.29 nM
   
mTOR inhibitor-17
mTOR, IC50: 0.68 nM
   
mTOR inhibitor-16
mTOR, IC50: 1.25 nM
   
mTOR inhibitor-10
mTOR, IC50: 0.7 nM